(Q46076333)

19 December 2017

editorial

0 references

title

Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality (English)

1 reference

19 December 2017

systemic lupus erythematosus

1 reference

1 reference

based on heuristic

inferred from title

author

Ricard Cervera i Segura

series ordinal

4

object named as

R Cervera

1 reference

19 December 2017

R O Escárcega

1

1 reference

19 December 2017

M Garcia-Carrasco

series ordinal

2

1 reference

19 December 2017

L J Jara

series ordinal

3

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

published in

Lupus

1 reference

19 December 2017

volume

18

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

383-386

1 reference

19 December 2017

Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Use of ezetimibe in the United States and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Over-the-counter sales of statins and other drugs for asymptomatic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

Mechanisms of disease: atherosclerosis in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

An Update on Aspirin in the Primary Prevention of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308101435

21 January 2018

Identifiers

DOI

10.1177/0961203308101435

1 reference

19 December 2017

1 reference

19 December 2017